Paul Tudor Jones Cabaletta Bio, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 21,314 shares of CABA stock, worth $156,444. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,314Holding current value
$156,444% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
168Shares Held
48.8MCall Options Held
300KPut Options Held
1.31M-
Black Rock Inc. New York, NY4.06MShares$29.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.5 Million0.0% of portfolio
-
Jennison Associates LLC3.42MShares$25.1 Million0.04% of portfolio
-
Fred Alger Management, LLC New York, NY3.11MShares$22.8 Million0.27% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$22.3 Million0.1% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $213M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...